These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 8934538)
21. In breast carcinoma dysadherin expression is correlated with invasiveness but not with E-cadherin. Batistatou A; Peschos D; Tsanou H; Charalabopoulos A; Nakanishi Y; Hirohashi S; Agnantis NJ; Charalabopoulos K Br J Cancer; 2007 May; 96(9):1404-8. PubMed ID: 17437014 [TBL] [Abstract][Full Text] [Related]
22. E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements. Christgen M; Bartels S; van Luttikhuizen JL; Bublitz J; Rieger LU; Christgen H; Stark H; Sander B; Lehmann U; Steinemann D; Derksen PWB; Kreipe H Mod Pathol; 2020 Dec; 33(12):2483-2498. PubMed ID: 32572153 [TBL] [Abstract][Full Text] [Related]
23. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry. Rakha EA; Armour JA; Pinder SE; Paish CE; Ellis IO Int J Cancer; 2005 May; 114(5):720-9. PubMed ID: 15609312 [TBL] [Abstract][Full Text] [Related]
24. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811 [TBL] [Abstract][Full Text] [Related]
25. Epithelial-cadherin gene is not mutated in ductal carcinomas of the breast. Kashiwaba M; Tamura G; Suzuki Y; Maesawa C; Ogasawara S; Sakata K; Satodate R Jpn J Cancer Res; 1995 Nov; 86(11):1054-9. PubMed ID: 8567396 [TBL] [Abstract][Full Text] [Related]
26. Loss of E-cadherin is the fundamental defect in diffuse-type gastric carcinoma and infiltrating lobular carcinoma of the breast. Chan JK; Wong CS Adv Anat Pathol; 2001 May; 8(3):165-72. PubMed ID: 11345240 [No Abstract] [Full Text] [Related]
27. Differential loss of heterozygosity profile on chromosome 3p in ductal and lobular breast carcinomas. de Oliveira MM; de Oliveira SF; Lima RS; de Andrade Urban C; Cavalli LR; de Souza Fonseca Ribeiro EM; Cavalli IJ Hum Pathol; 2012 Oct; 43(10):1661-7. PubMed ID: 22503535 [TBL] [Abstract][Full Text] [Related]
28. The role of E-cadherin in low-grade ductal breast tumourigenesis. Roylance R; Droufakou S; Gorman P; Gillett C; Hart IR; Hanby A; Tomlinson I J Pathol; 2003 May; 200(1):53-8. PubMed ID: 12692841 [TBL] [Abstract][Full Text] [Related]
29. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Moll R; Mitze M; Frixen UH; Birchmeier W Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859 [TBL] [Abstract][Full Text] [Related]
30. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Lei H; Sjöberg-Margolin S; Salahshor S; Werelius B; Jandáková E; Hemminki K; Lindblom A; Vorechovský I Int J Cancer; 2002 Mar; 98(2):199-204. PubMed ID: 11857408 [TBL] [Abstract][Full Text] [Related]
31. Loss of chromosome 16q in lobular carcinoma in situ. Etzell JE; Devries S; Chew K; Florendo C; Molinaro A; Ljung BM; Waldman FM Hum Pathol; 2001 Mar; 32(3):292-6. PubMed ID: 11274638 [TBL] [Abstract][Full Text] [Related]
32. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online. Becker KF; Reich U; Schott C; Becker I; Berx G; van Roy F; Höfler H Hum Mutat; 1999; 13(2):171. PubMed ID: 10094558 [TBL] [Abstract][Full Text] [Related]
33. Low frequency of E-cadherin alterations in familial breast cancer. Salahshor S; Haixin L; Huo H; Kristensen VN; Loman N; Sjöberg-Margolin S; Borg A; Børresen-Dale AL; Vorechovsky I; Lindblom A Breast Cancer Res; 2001; 3(3):199-207. PubMed ID: 11305955 [TBL] [Abstract][Full Text] [Related]
34. Mutations of the E-cadherin gene in human gynecologic cancers. Risinger JI; Berchuck A; Kohler MF; Boyd J Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649 [TBL] [Abstract][Full Text] [Related]
35. Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Dabbs DJ; Schnitt SJ; Geyer FC; Weigelt B; Baehner FL; Decker T; Eusebi V; Fox SB; Ichihara S; Lakhani SR; Palacios J; Rakha E; Richardson AL; Schmitt FC; Tan PH; Tse GM; Vincent-Salomon A; Ellis IO; Badve S; Reis-Filho JS Am J Surg Pathol; 2013 Jul; 37(7):e1-11. PubMed ID: 23759937 [TBL] [Abstract][Full Text] [Related]
36. CDH1 germline mutations and hereditary lobular breast cancer. Corso G; Intra M; Trentin C; Veronesi P; Galimberti V Fam Cancer; 2016 Apr; 15(2):215-9. PubMed ID: 26759166 [TBL] [Abstract][Full Text] [Related]
37. Infrequent mutation of the H-cadherin gene on chromosome 16q24 in human breast cancers. Miki Y; Katagiri T; Nakamura Y Jpn J Cancer Res; 1997 Aug; 88(8):701-4. PubMed ID: 9330599 [TBL] [Abstract][Full Text] [Related]
38. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Rakha EA; Teoh TK; Lee AH; Nolan CC; Ellis IO; Green AR Histopathology; 2013 Apr; 62(5):695-701. PubMed ID: 23347178 [TBL] [Abstract][Full Text] [Related]
39. CCND1- and ERBB2-gene deregulation and PTEN mutation analyses in invasive lobular carcinoma of the breast. Mercapide J; Zhang SY; Fan X; Furió-Bacete V; Schneider J; López de la Osa I; Patchefsky AS; Klein-Szanto AJ; Castresana JS Mol Carcinog; 2002 Sep; 35(1):6-12. PubMed ID: 12203362 [TBL] [Abstract][Full Text] [Related]
40. Mapping the chromosome 16 cadherin gene cluster to a minimal deleted region in ductal breast cancer. Chalmers IJ; Aubele M; Hartmann E; Braungart E; Werner M; Höfler H; Atkinson MJ Cancer Genet Cytogenet; 2001 Apr; 126(1):39-44. PubMed ID: 11343777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]